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BACKGROUND
Reports on the incidence and causes of sudden cardiac death among young ath-
letes have relied largely on estimated rates of participation and varied methods of 
reporting. We sought to investigate the incidence and causes of sudden cardiac 
death among adolescent soccer players in the United Kingdom.
METHODS
From 1996 through 2016, we screened 11,168 adolescent athletes with a mean 
(±SD) age of 16.4±1.2 years (95% of whom were male) in the English Football As-
sociation (FA) cardiac screening program, which consisted of a health question-
naire, physical examination, electrocardiography, and echocardiography. The FA 
registry was interrogated to identify sudden cardiac deaths, which were confirmed 
with autopsy reports.
RESULTS
During screening, 42 athletes (0.38%) were found to have cardiac disorders that 
are associated with sudden cardiac death. A further 225 athletes (2%) with con-
genital or valvular abnormalities were identified. After screening, there were 23 
deaths from any cause, of which 8 (35%) were sudden deaths attributed to cardiac 
disease. Cardiomyopathy accounted for 7 of 8 sudden cardiac deaths (88%). Six 
athletes (75%) with sudden cardiac death had had normal cardiac screening re-
sults. The mean time between screening and sudden cardiac death was 6.8 years. 
On the basis of a total of 118,351 person-years, the incidence of sudden cardiac 
death among previously screened adolescent soccer players was 1 per 14,794 per-
son-years (6.8 per 100,000 athletes).
CONCLUSIONS
Diseases that are associated with sudden cardiac death were identified in 0.38% of 
adolescent soccer players in a cohort that underwent cardiovascular screening. The 
incidence of sudden cardiac death was 1 per 14,794 person-years, or 6.8 per 100,000 
athletes; most of these deaths were due to cardiomyopathies that had not been 
detected on screening. (Funded by the English Football Association and others.)
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Outcomes of Cardiac Screening in Soccer Players
Sudden cardiac death in a seemingly healthy athlete invariably prompts discus-sion about possible preventative screening 
strategies. The absence of a systematic registry of 
deaths in young athletes (<35 years old) has been 
a major obstacle to ascertaining the precise inci-
dence of sudden cardiac death in this group; 
estimates vary between 0.5 and 13 deaths per 
100,000 athletes,1,2 depending on the population 
studied and methods of data collection used.3 
Furthermore, data on outcomes in adolescent 
athletes who have been screened for cardiovascu-
lar disease in a well-defined cohort are lacking.
The English Football Association (FA) has run 
a mandatory cardiac screening program for ado-
lescent athletes in the United Kingdom since 
1997, with a total of more than 11,000 athletes 
screened since its inception. The aim of this 
study was to determine the incidence and causes 
of sudden cardiac death in this well-defined 
population of previously screened soccer players.
Me thods
Screening Program
Between January 1, 1996, and December 31, 2016, 
a total of 11,168 soccer players at clubs affiliated 
with the FA underwent mandatory cardiovascular 
screening. The program encompassed all youth 
academy players (15 to 17 years of age) across 
the 92 professional clubs in the soccer league 
system who had excelled within the preceding 
5 years. All such high-ranking players were of-
fered a formal remunerated scholar contract 
(usually at the age of 16 years) with a view to 
progressing to a professional senior career. 
Written informed consent for screening was ob-
tained from each player by the team doctor. 
Written informed consent from a parent or 
guardian was required for athletes younger than 
16 years of age, in accordance with the FA gov-
ernance department.
Athletes underwent assessment with a health 
questionnaire (Fig. S1 in the Supplementary Ap-
pendix, available with the full text of this article 
at NEJM.org), physical examination, 12-lead elec-
trocardiography (ECG), and echocardiography. 
Mobile screening units staffed by accredited 
sonographers visited the clubs to conduct the 
evaluations, and the results were reviewed by an 
expert regional cardiologist who was a member 
of the FA-approved cardiology consensus panel. 
A formal report was sent to the FA medical de-
partment, in which each athlete was classified in 
one of three categories on the basis of the evalu-
ation: normal; further evaluation needed, if an 
abnormality was detected that required further 
investigation to confirm or refute the presence 
of cardiac disease; or cardiac disease detected. 
The last category was subclassified into disorders 
that are associated with sudden cardiac death or 
those encompassing congenital septal and valvu-
lar conditions.
Further investigations were performed at re-
gional specialist centers. Athletes with T-wave 
inversion, abnormally enlarged cardiac dimen-
sions, or a low ejection fraction and those fulfill-
ing echocardiographic criteria for left ventricular 
noncompaction underwent maximal exercise stress 
testing, 24-hour Holter monitoring, and cardio-
vascular magnetic resonance imaging (MRI). 
Athletes with a prolonged QT interval under-
went exercise stress testing and 24-hour Holter 
monitoring, and athletes with a Wolff–Parkinson–
White ECG pattern were risk-stratified on the 
basis of an exercise test and an electrophysiologi-
cal study. From 2012 onward, there was sufficient 
evidence indicating that among black athletes, 
anterior T-wave inversion was a common variant 
that was not associated with structural heart dis-
ease or serious cardiac arrhythmias4; therefore, 
asymptomatic black athletes with this repolariza-
tion abnormality did not undergo further investi-
gation unless the echocardiogram was abnormal.5 
In 2013, we ceased to investigate athletes who 
fulfilled echocardiographic criteria for left ven-
tricular noncompaction but had a normal ECG 
and normal cardiac function.6 The results of all 
the investigations were reported back to the FA 
headquarters and reviewed independently by the 
first and last authors.
Diagnosis of Disorders Associated  
with Sudden Cardiac Death
The diagnosis of hypertrophic cardiomyopathy 
was based on a left ventricular wall thickness of 
15 mm or greater in any myocardial segment on 
echocardiography or cardiovascular MRI in the 
absence of another condition capable of produc-
ing left ventricular hypertrophy.7-9 The diagnosis 
of dilated cardiomyopathy was considered if the 
patient had a dilated left ventricle (a left ventricu-
lar end-diastolic dimension of >59 mm in males 
and >53 mm in females) and a reduced ejection 
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fraction (<52% in males and <54% in females).10,11 
The diagnosis of arrhythmogenic right ventricu-
lar cardiomyopathy was based on published cri-
teria.12,13 The diagnosis of long-QT syndrome 
was based on a corrected QT (QTc) interval of 
500 msec or greater or of 470 to 490 msec in 
association with notched T waves in at least 
three leads, paradoxical prolongation of the 
QT interval with exercise, or a positive genetic 
test.14,15 Identification of the Wolff–Parkinson–
White ECG pattern was based on findings of a 
short PR interval and a slurred upstroke to the 
QRS complex.
Recommendations for Follow-up Assessments 
or Exclusion from Play
Some of the screened athletes had abnormal 
T-wave inversion but structurally normal hearts, 
and others had borderline-abnormal cardiac di-
mensions but no other features to support the 
diagnosis of cardiomyopathy. These athletes were 
investigated with ECG and echocardiography per-
formed every year and cardiovascular MRI per-
formed every 2 years. Athletes with congenital 
valvular abnormalities or septal defects were mon-
itored with annual ECG and echocardiography.
Athletes with cardiac disorders that are associ-
ated with sudden cardiac death were advised not 
to compete and were discharged into the care of 
the National Health Service. Decisions to dis-
qualify such athletes were made by the FA cardi-
ology consensus panel after discussions in ac-
cordance with current exercise recommendations 
of the European Society of Cardiology and the 
American Heart Association.16-18 The decision was 
relayed to the player in the presence of the 
player’s parent or guardian and the club doctor 
by the regional cardiologist.
Outcomes
Calculation of the follow-up period per athlete 
was based on the number of years of competi-
tion within the FA, which was determined from 
the FA registry of players. Deaths among athletes 
were ascertained through the development of a 
database that was compiled from voluntary re-
ports to the FA. A second method to ascertain 
the number of deaths was through a secure sur-
vey that was sent to health professionals at each 
of the 92 FA-affiliated clubs, asking specifically 
about deaths from any cause. In addition, regu-
lar Internet searches had been performed since 
2005, with the use of three different search en-
gines (Google, Yahoo, and MSN search [Bing]) 
and at least 16 keywords (student, athlete, col-
lapsed, died, death, heart, cardiac, arrest, attack, 
soccer, running, school, unknown, college, defi-
brillator, and saved).
Death certificates were obtained from the U.K. 
government for all deceased persons in the co-
hort to ascertain the causes of death, which were 
categorized broadly as accidental, suicide, drug-
related, cancer, or cardiac causes. Autopsy data 
were available in all cases of sudden cardiac 
death, and diagnoses were based on previously 
established pathological criteria in conjunction 
with consultation with an expert cardiac pa-
thologist.19
Data on survival status during the screening 
program over the 20-year period among athletes 
who had diagnoses of cardiac disorders that are 
associated with sudden cardiac death were ob-
tained from attending cardiologists, most of 
whom were part of the expert FA consensus panel.
R esult s
Further Evaluation after Screening
The mean (±SD) age of the 11,168 soccer players 
who underwent cardiovascular screening was 
16.4±1.2 years; 10,581 (95%) of the athletes were 
male. In the entire cohort, 830 athletes (7%) 
underwent further investigation after prelimi-
nary assessment. Among these athletes, 104 (0.9%) 
reported symptoms that were deemed noncar-
diac in origin after assessment by a cardiologist. 
Among the remaining 726 athletes, 292 (3% of 
the total cohort) underwent investigation for 
T-wave inversion (anterior [153], inferior or lateral 
[114], or widespread [25]). A total of 25 athletes 
(0.2%) underwent investigation for a prolonged 
QTc interval. A further 409 athletes (4%) under-
went cardiovascular MRI because of ventricular 
remodeling consistent with cardiomyopathy.9 
Specifically, 229 athletes (2%) had a left ventricu-
lar wall thickness of 13 mm or greater; 106 (0.9%) 
had an enlarged left ventricular cavity with a 
borderline-low ejection fraction (of 50 to 52%)10; 
80 athletes (0.7%) had a suspected right ventricu-
lar regional wall-motion abnormality, and 19 
(0.2%) had increased left ventricular trabeculation 
and a mildly reduced ejection fraction (of ≤50%).6 
Twenty-five athletes had abnormal T-wave inver-
sion and enlarged cardiac dimensions.
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Detection of Cardiac Disease
A total of 42 athletes (0.38%) were found to have 
cardiac disorders that are associated with sudden 
cardiac death (Fig. 1 and Table 1). Five (0.04%) 
had a diagnosis of hypertrophic cardiomyopathy, 
2 (0.02%) of arrhythmogenic right ventricular 
cardiomyopathy,12 and 1 (0.01%) of dilated car-
diomyopathy. Three athletes (0.03%) had a diag-
nosis of long-QT syndrome. Two athletes (0.02%) 
had a diagnosis of an anomalous origin of a 
coronary artery, and 3 (0.03%) were found to have 
a bicuspid aortic valve associated with either 
aortic-root enlargement of 50 mm or greater (1) 
or severe aortic regurgitation (2). A total of 26 
(0.23%) athletes had the Wolff–Parkinson–White 
ECG pattern (Table S1 in the Supplementary Ap-
pendix).
Among the 42 athletes with cardiac disorders 
that are associated with sudden cardiac death, 
2 (5%) had symptoms, 1 (2%) had an abnormal-
ity detected on cardiac examination, and 1 (2%) 
had both symptoms and an abnormality detected 
on examination (Table 2). Abnormal ECGs were 
obtained in 36 of these athletes (86%), and ab-
normal echocardiograms in 12 (29%).
There were 225 athletes (2%) with other car-
diac disorders, including congenital septal and 
valvular abnormalities (Fig. 1). The diagnoses in 
all of these athletes were made with the use of 
echocardiography; 48 of the athletes (21%) had 
an abnormal ECG, and 74 (33%) had an abnor-
mality detected on examination (Table 2).
Interventions and Outcomes
Athletes with a diagnosis of cardiomyopathy (8) 
or long-QT syndrome (3) were advised against 
participation in competitive soccer. None of the 
athletes with cardiomyopathy were deemed to 
have a sufficiently high-risk profile to warrant a 
prophylactic implantable cardioverter–defibrilla-
tor.7,20,21 The 3 athletes with long-QT syndrome 
began treatment with beta-blockers. Both athletes 
with anomalous coronary-artery origins under-
went corrective surgery and returned to play. The 
3 athletes with bicuspid aortic valves underwent 
surgical intervention for aortic-root dilatation (1) 
or severe aortic regurgitation (2) and returned to 
play (Table 1). All 26 athletes with the Wolff–
Parkinson–White ECG pattern underwent risk 
stratification, and 24 underwent ablation before 
returning to play. The remaining 2 athletes with 
the Wolff–Parkinson–White pattern were deemed 
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to have low-risk accessory conduction pathways 
that were not ablated, and they continued to com-
pete (Table S1 in the Supplementary Appendix).
Of the 42 athletes who, during screening, 
received diagnoses of cardiac disorders that are 
associated with sudden cardiac death, 40 (95%) 
were alive at the end of the study period. Two 
athletes with a diagnosis of hypertrophic cardio-
myopathy continued to compete despite medical 
advice and died subsequently during intensive 
exercise.
Among the 225 athletes with other cardiac 
disorders, 7 with an atrial septal defect and 1 with 
a ventricular septal defect had hemodynamic in-
dications to warrant percutaneous closure before 
returning to play. The remaining 217 athletes 
(97%) had mild disease and were permitted to 
compete. We could not establish a cardiac diag-
nosis in 276 athletes (2%) who had abnormal 
T-wave inversion or borderline abnormal cardiac 
dimensions. All these athletes continued to com-
pete but remained under clinical surveillance.
All-Cause Mortality
Of the 92 professional clubs, 86 (93%) responded 
to the questionnaire regarding all-cause mortal-
ity. During a mean follow-up period of 10.6±8.3 
years, there were 23 deaths. The causes of death 
included road traffic accidents (7 deaths [30%]), 
cancer (5 [22%]), drug overdose (2 [9%]), and 
suicide (1 [4%]). Cardiac disorders accounted for 
8 deaths (35%), all of which were sudden and 
occurred during exercise (Fig. 2).
Sudden Cardiac Deaths
Autopsy data were available for all sudden car-
diac deaths. Among the athletes who died from 
cardiac disorders, the mean time between screen-
ing and sudden death was 6.8 years (range, 0.1 to 
13.2). Cardiomyopathies were the most common 
cause of death and accounted for 7 of 8 (88%) 
sudden cardiac deaths (Table 3). There were a 
total of 118,351 person-years of follow-up over 
the 20-year study period. The resulting overall 
incidence of sudden cardiac death among ado-
Condition No. of Athletes No. of Athletes with Abnormal Result
History Examination ECG Echocardiography
Any cardiac condition 267 6 76 84 237
Condition associated with sudden cardiac death 42 3 2 36 12
Hypertrophic cardiomyopathy 5 0 0 5 5
Arrhythmogenic right ventricular cardiomyopathy 2 1 0 1 2
Dilated cardiomyopathy 1 1 0 1 1
Coronary-artery anomalies 2 0 0 0 2
Bicuspid aortic valve–associated disease* 3 1 2 0 3
Long-QT syndrome 3 0 0 3 0
Wolff–Parkinson–White ECG pattern 26 0 0 26 0
Other cardiac condition 225 3 74 48 225
Bicuspid aortic valve 68 1 32 15 68
Atrial septal defect 62 1 6 26 62
Aortic regurgitation 29 0 16 2 29
Mitral-valve prolapse 24 0 12 3 24
Patent ductus arteriosus 18 0 1 1 18
Ventricular septal defect 13 0 3 1 13
Pulmonary stenosis 9 1 4 0 9
Cor triatriatum 2 0 0 0 2
*  Bicuspid aortic valve–associated disease includes bicuspid aortic valve with either aortic-root enlargement or severe aortic regurgitation.
Table 2. Summary of Cardiac Conditions Detected According to Screening Tool.
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lescent soccer players was 1 per 14,794 person-
years, or 6.8 per 100,000 athletes.
Of the 8 sudden cardiac deaths, 6 (75%) were 
in athletes who had normal findings during pre-
liminary screening (Fig. 1 and Table 3). Variation 
in test interpretation could have accounted for 
the normal findings. Therefore, 50 deidentified 
ECGs and corresponding echocardiograms from 
the cohort were analyzed by two independent 
experts in inherited cardiac diseases who were 
unaware of the outcomes. The ECGs and echo-
cardiograms were from 45 athletes whose results 
had been interpreted as normal, including the 
6 decedents, and 5 athletes with abnormal re-
sults, including 1 athlete each with a diagnosis 
of arrhythmogenic right ventricular cardiomyopa-
thy, dilated cardiomyopathy, hypertrophic cardio-
myopathy, long QT interval, and the Wolff–Par-
kinson–White ECG pattern. Blind reading showed 
100% agreement between the two reviewers for 
the 6 decedents with normal results (Table 3).
Cost of Diagnosis
On the basis of the U.K. National Health Service 
tariffs,22 the cost of preliminary investigation 
with consultation (£160 [$213 in U.S. dollars]), 
ECG (£25 [$33]), and echocardiography (£72 
[$96]) would amount to £257 ($342) per athlete, 
resulting in an initial cost of screening 11,168 
athletes of £2,870,176 ($3,817,334). The cost of 
further investigating 830 athletes was £375,587 
($499,531), with a total estimated outlay of 
£3,245,763 ($4,316,865). The cost to detect seri-
ous cardiac disease associated with sudden car-
diac death (42 athletes) was £77,280 ($102,782) 
per case, and the cost to identify any cardiac dis-
order (267 athletes) was £12,156 ($16,167) per case.
Discussion
We report the outcomes of cardiovascular screen-
ing of adolescent soccer players, determined with 
the use of data from the FA in the United King-
dom. The prevalence of disorders associated with 
sudden cardiac death in young athletes was 
0.38%, which is similar to that reported in other 
screening programs.23-25 Congenital septal and 
minor valvular disorders were detected in an ad-
ditional 2% of the athletes, leading to an overall 
prevalence of 2.4% for all cardiac conditions.
In this cohort, electrical diseases accounted 
for 29 (69%) of the 42 cases of cardiac disorders 
that are associated with sudden cardiac death, 
whereas the primary cardiomyopathies account-
ed for only 8 (19%) of these cases. Anomalous 
coronary-artery origins accounted for 2 (5%) of 
the cases but were almost certainly underrepre-
sented because of the limitations of echocar-
diography in detecting this type of disorder. The 
remaining 3 (7%) of the 42 cases were due to 
advanced aortic-valve disease. History, findings 
on physical examination, and ECG were abnor-
mal in 7%, 5%, and 86%, respectively, of athletes 
with cardiac disorders associated with sudden 
cardiac death.
Hypertrophic cardiomyopathy was the most 
commonly detected cardiomyopathy, and all 
5 athletes in whom this condition was detected 
had an abnormal ECG and echocardiogram. The 
prevalence of hypertrophic cardiomyopathy among 
these elite adolescent soccer players was 1 in 
1861 athletes (including 1 case not detected by 
screening), which is considerably lower than that 
reported in the general population, raising the 
possibility that athletes with a more advanced 
phenotype at this age may have been selected 
out of competition because of reduced cardio-
respiratory capacity.26,27 Age-related penetrance of 
hypertrophic cardiomyopathy is also an important 
consideration, since in many affected persons the 
disease is not expressed during adolescence.28-33 
The prevalence of arrhythmogenic right ventric-
Figure 2. Causes of Death among the 23 Screened 
 Adolescent Soccer Players Who Died.
Cancer,
22%
Cardiac cause,
35%
Road traffic
accident,
30%
Drug
overdose,
9%
Suicide,
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ular cardiomyopathy was 1 in 2792 athletes; this 
disorder has a highly variable clinical course, and 
the mean age at presentation is 31±13 years.34 
Exercise has been shown to accelerate the phe-
notypic manifestations of this condition,35,36 and 
years of intensive training regimes may well 
contribute to the unmasking of phenotypes that 
could not be detected during adolescence.
Of the seven athletes who died suddenly from 
cardiomyopathy, five (71%) had a normal ECG 
and echocardiogram at a mean age of 16 years. 
Screening at this age seems logistically appro-
priate, given that most people will be postpuber-
tal and will have overt evidence of any electrical 
or structural cardiac abnormalities. However, this 
study shows that screening during late adoles-
cence will fail to detect a substantial proportion 
of athletes who have or will eventually have a 
cardiomyopathy, either because the disease is not 
yet manifest or because ECG and echocardiogra-
phy are not sensitive enough to detect early dis-
ease in some adolescents.
This systematic study revealed that the inci-
dence of sudden cardiac death among screened 
16-year-old soccer players was approximately 
1 per 14,800 person-years, or 6.8 per 100,000 
athletes. This figure is considerably higher than 
previous estimates among athletes who have been 
screened with the use of history and physical 
examination alone or who have not undergone 
cardiac screening.1-3,37-41 Sudden cardiac death may 
be more common in some sports than in others; 
these results in adolescent soccer players are 
similar to findings previously reported in male 
basketball players.3 The National Collegiate Ath-
letic Association in the United States adopted a 
policy in 2014 requiring all affiliated institutions 
to report cases of catastrophic injury or death. 
Such mandatory reporting initiatives across other 
sporting organizations would offer an important 
source of prospective data in already well-defined 
populations.
Several limitations of our study should be 
noted. For our data, we relied on voluntary re-
porting of sudden cardiac deaths by clubs and 
on retrospective recall. Although we confirmed 
all sudden cardiac deaths with death certificates 
and autopsy reports, it is possible that we did 
not capture all cases. Our results therefore rep-
resent the minimum incidence of sudden cardiac 
death among screened adolescent soccer players. 
The end point of our study was sudden death, 
and therefore we are unable to comment on the 
number of athletes in whom a quiescent cardio-
myopathy may have developed after the initial 
screen or who survived a sudden cardiac arrest. 
Finally, our study included only adolescent soccer 
players of the highest ability and may underesti-
mate the burden of cardiac disorders or preva-
lence of sudden cardiac death among non-elite 
or older players.
In conclusion, we investigated the results of 
Athlete 
No.
Sex and 
Age Race*
Years from 
Screening  
to Death Diagnosis
Initial Screening 
Result
Blind Reading 
(Reviewer 1)
Blind Reading 
(Reviewer 2)
1 M, 16.8 yr Black 0.1 Idiopathic left ventricular hypertrophy Negative Negative Negative
2 M, 16.6 yr Mixed 1.0 Hypertrophic cardiomyopathy Abnormal ECG and 
echocardiogram
NA NA
3 M, 16.6 yr Black 3.3 Hypertrophic cardiomyopathy Negative Negative Negative
4 M, 16.3 yr Black 7.7 Dilated cardiomyopathy Negative Negative Negative
5 M, 17.0 yr White 7.9 Arrhythmogenic right ventricular 
 cardiomyopathy
Negative Negative Negative
6 M, 17.2 yr White 9.7 Arrhythmogenic right ventricular 
 cardiomyopathy
Negative Negative Negative
7 M, 15.7 yr White 11.5 Hypertrophic cardiomyopathy Abnormal ECG and 
echocardiogram
NA NA
8 M, 16.8 yr White 13.2 Sudden arrhythmic death syndrome Negative Negative Negative
*  Race was reported by the athlete or the parent or guardian.
Table 3. Characteristics of Athletes with Sudden Cardiac Death.
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cardiovascular screening of a large cohort of 
adolescent soccer players in the United Kingdom. 
Diseases associated with sudden cardiac death, 
the majority of them electrical cardiac disorders, 
were identified in 0.38% of participants. The 
incidence of sudden cardiac death among these 
previously screened athletes was approximately 
1 per 14,800 person-years, or 6.8 per 100,000 
athletes. Most of these deaths were due to cardio-
myopathies that were not detected on screening.
Supported by the English Football Association, Cardiac Risk 
in the Young (to Drs. Malhotra and Dhutia), and the Charles 
Wolfson charitable trust (to Dr. Finocchiaro).
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